E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma

Henry T. Lynch, William Grady, Jane F. Lynch, Karen D. Tsuchiya, Georgia Wiesner, Sanford D. Markowitz

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The E-cadherin mutation has been identified in a subset of families with multiple cases of diffuse gastric carcinoma. However, the true penetrance of this mutation and its association with other carcinomas in such families remains elusive. We aim to show the importance of DNA-based genetic counseling in hereditary diffuse gastric carcinoma. The proband was self-referred after three of his siblings died of diffuse gastric carcinoma. Medical and pathology records confirmed diagnoses. The family was educated about diffuse gastric carcinoma. Analysis for the 70G→T mutation was performed by sequencing genomic DNA from lymphocyte pellets. DNA results and genetic counseling were provided individually to those tested. Twenty-four family members were tested for the E-cadherin mutation. Nine were found to be positive and 15 were negative. Three who tested positive and were affected are now deceased. None of the 19 patients counseled wanted results sent to their physicians once they recognized the potential for insurance discrimination. None had undergone endoscopic ultrasound. Three who were positive for the E-cadherin mutation expressed strong interest in prophylactic gastrectomy. The E-cadherin mutation strongly predicts susceptibility to diffuse gastric carcinoma. Emotional stress in at-risk patients, the limited knowledge of the mutation's penetrance, and limitations of available screening mandate patient-centered genetic counseling. Copyright (C) 2000 Elsevier Science Inc.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalCancer Genetics and Cytogenetics
Volume122
Issue number1
DOIs
StatePublished - Oct 1 2000

Fingerprint

Genetic Counseling
Cadherins
Stomach
Carcinoma
Mutation
Penetrance
DNA
Gastrectomy
Insurance
DNA Sequence Analysis
Psychological Stress
Medical Records
Siblings
Lymphocytes
Pathology
Physicians

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma. / Lynch, Henry T.; Grady, William; Lynch, Jane F.; Tsuchiya, Karen D.; Wiesner, Georgia; Markowitz, Sanford D.

In: Cancer Genetics and Cytogenetics, Vol. 122, No. 1, 01.10.2000, p. 1-6.

Research output: Contribution to journalArticle

Lynch, Henry T. ; Grady, William ; Lynch, Jane F. ; Tsuchiya, Karen D. ; Wiesner, Georgia ; Markowitz, Sanford D. / E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma. In: Cancer Genetics and Cytogenetics. 2000 ; Vol. 122, No. 1. pp. 1-6.
@article{4941a088322c4b98a775386ed5cf449e,
title = "E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma",
abstract = "The E-cadherin mutation has been identified in a subset of families with multiple cases of diffuse gastric carcinoma. However, the true penetrance of this mutation and its association with other carcinomas in such families remains elusive. We aim to show the importance of DNA-based genetic counseling in hereditary diffuse gastric carcinoma. The proband was self-referred after three of his siblings died of diffuse gastric carcinoma. Medical and pathology records confirmed diagnoses. The family was educated about diffuse gastric carcinoma. Analysis for the 70G→T mutation was performed by sequencing genomic DNA from lymphocyte pellets. DNA results and genetic counseling were provided individually to those tested. Twenty-four family members were tested for the E-cadherin mutation. Nine were found to be positive and 15 were negative. Three who tested positive and were affected are now deceased. None of the 19 patients counseled wanted results sent to their physicians once they recognized the potential for insurance discrimination. None had undergone endoscopic ultrasound. Three who were positive for the E-cadherin mutation expressed strong interest in prophylactic gastrectomy. The E-cadherin mutation strongly predicts susceptibility to diffuse gastric carcinoma. Emotional stress in at-risk patients, the limited knowledge of the mutation's penetrance, and limitations of available screening mandate patient-centered genetic counseling. Copyright (C) 2000 Elsevier Science Inc.",
author = "Lynch, {Henry T.} and William Grady and Lynch, {Jane F.} and Tsuchiya, {Karen D.} and Georgia Wiesner and Markowitz, {Sanford D.}",
year = "2000",
month = "10",
day = "1",
doi = "10.1016/S0165-4608(00)00273-9",
language = "English",
volume = "122",
pages = "1--6",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma

AU - Lynch, Henry T.

AU - Grady, William

AU - Lynch, Jane F.

AU - Tsuchiya, Karen D.

AU - Wiesner, Georgia

AU - Markowitz, Sanford D.

PY - 2000/10/1

Y1 - 2000/10/1

N2 - The E-cadherin mutation has been identified in a subset of families with multiple cases of diffuse gastric carcinoma. However, the true penetrance of this mutation and its association with other carcinomas in such families remains elusive. We aim to show the importance of DNA-based genetic counseling in hereditary diffuse gastric carcinoma. The proband was self-referred after three of his siblings died of diffuse gastric carcinoma. Medical and pathology records confirmed diagnoses. The family was educated about diffuse gastric carcinoma. Analysis for the 70G→T mutation was performed by sequencing genomic DNA from lymphocyte pellets. DNA results and genetic counseling were provided individually to those tested. Twenty-four family members were tested for the E-cadherin mutation. Nine were found to be positive and 15 were negative. Three who tested positive and were affected are now deceased. None of the 19 patients counseled wanted results sent to their physicians once they recognized the potential for insurance discrimination. None had undergone endoscopic ultrasound. Three who were positive for the E-cadherin mutation expressed strong interest in prophylactic gastrectomy. The E-cadherin mutation strongly predicts susceptibility to diffuse gastric carcinoma. Emotional stress in at-risk patients, the limited knowledge of the mutation's penetrance, and limitations of available screening mandate patient-centered genetic counseling. Copyright (C) 2000 Elsevier Science Inc.

AB - The E-cadherin mutation has been identified in a subset of families with multiple cases of diffuse gastric carcinoma. However, the true penetrance of this mutation and its association with other carcinomas in such families remains elusive. We aim to show the importance of DNA-based genetic counseling in hereditary diffuse gastric carcinoma. The proband was self-referred after three of his siblings died of diffuse gastric carcinoma. Medical and pathology records confirmed diagnoses. The family was educated about diffuse gastric carcinoma. Analysis for the 70G→T mutation was performed by sequencing genomic DNA from lymphocyte pellets. DNA results and genetic counseling were provided individually to those tested. Twenty-four family members were tested for the E-cadherin mutation. Nine were found to be positive and 15 were negative. Three who tested positive and were affected are now deceased. None of the 19 patients counseled wanted results sent to their physicians once they recognized the potential for insurance discrimination. None had undergone endoscopic ultrasound. Three who were positive for the E-cadherin mutation expressed strong interest in prophylactic gastrectomy. The E-cadherin mutation strongly predicts susceptibility to diffuse gastric carcinoma. Emotional stress in at-risk patients, the limited knowledge of the mutation's penetrance, and limitations of available screening mandate patient-centered genetic counseling. Copyright (C) 2000 Elsevier Science Inc.

UR - http://www.scopus.com/inward/record.url?scp=0034305948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034305948&partnerID=8YFLogxK

U2 - 10.1016/S0165-4608(00)00273-9

DO - 10.1016/S0165-4608(00)00273-9

M3 - Article

VL - 122

SP - 1

EP - 6

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 1

ER -